Halpern Financial, Inc. Abbott Laboratories Transaction History

Halpern Financial, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$109.52 - $120.96 $18,399 - $20,321	-168 Reduced 49.12%	174 $19.4 Million
Q4 2023 Jan 19, 2024	BUY	$90.19 - $110.4 $6,674 - $8,169	74 Added 27.61%	342 $37.5 Million
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $25,602 - $30,718	268 New	268 $26 Million
Q1 2023 Sep 21, 2023	SELL	$96.86 - $114.01 $1,937 - $2,280	-20 Closed	0 $0
Q1 2022 Sep 21, 2023	SELL	$114.02 - $139.04 $17,217 - $20,995	-151 Reduced 88.3%	20 $2.37 Million
Q4 2021 Sep 21, 2023	SELL	$115.53 - $141.46 $15,018 - $18,389	-130 Reduced 43.19%	171 $24.1 Million
Q3 2021 Sep 21, 2023	BUY	$116.66 - $129.06 $15,165 - $16,777	130 Added 76.02%	301 $35.6 Million
Q2 2021 Sep 21, 2023	SELL	$105.79 - $124.53 $1,057 - $1,245	-10 Reduced 5.52%	171 $19.8 Million
Q1 2020 Sep 21, 2023	SELL	$62.82 - $91.86 $502 - $734	-8 Reduced 4.23%	181 $14.3 Million
Q4 2019 Sep 21, 2023	BUY	$78.51 - $87.4 $14,838 - $16,518	189 New	189 $16.4 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Halpern Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Halpern Financial, Inc. with notifications on news.